Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelmnews2024-01-31T19:10:58+00:00January 31st, 2024|The New York Times|
Six Reasons Drug Prices Are So High in the U.S.news2024-01-17T18:53:05+00:00January 17th, 2024|The New York Times|
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canadanews2024-01-05T18:06:59+00:00January 5th, 2024|The New York Times|
Possible Ways to Ease Drug Shortagesnews2023-12-19T16:05:37+00:00December 19th, 2023|The New York Times|
Behind the Shortage Keeping Cancer Patients From Chemonews2023-12-19T08:01:01+00:00December 19th, 2023|The New York Times|
CVS Says It Will Change the Way Its Pharmacies Are Paidnews2023-12-05T23:27:46+00:00December 5th, 2023|The New York Times|
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiarnews2023-10-26T09:02:55+00:00October 26th, 2023|The New York Times|
How Much Do Ozempic and Wegovy Cost? Not What You Think.news2023-10-22T07:00:20+00:00October 22nd, 2023|The New York Times|
Drug Makers Agree to Negotiate With Medicare on Prices of 10 Medicationsnews2023-10-03T22:38:52+00:00October 3rd, 2023|The New York Times|
A Performance Review for President Bidennews2023-09-07T16:07:32+00:00September 7th, 2023|The New York Times|
